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Abstract: 
Background: Forensic autopsy strategies may improve differential diagnostics both post-mortem and ante-mortem and aid in clinical 
settings concerning preventive efforts for premature mortality. Excess mortality and reduced life expectancy affect persons with 
severe mental illnesses (SMI) for multi-faceted reasons that remain controversial. Somatic conditions, medical treatment and lifestyle 
diseases, which are primarily examined in the living, contribute to premature deaths. The underlying pathophysiological mechanisms 
are unclear, though, and the benefits of a focused, standardised autopsy remain unproven. We have developed and implemented an 
optimised molecular–biological autopsy for deceased persons with SMI. Our aim is to map the occurrence of 1) somatic diseases and 
organ changes; 2) metabolic syndrome; 3) use and abuse of alcohol, pharmaceuticals and psychoactive substances; 4) pharmacokinetic 
and pharmacodynamic factors in the metabolism of pharmaceuticals; and 5) genetic variations (acquired and/or congenital) in sudden 
cardiac death. Additionally, we hope to contribute to diagnostic treatments and preventive measures to benefit those living with SMI.
Methods: SURVIVE: let the dead help the living is a prospective, autopsy-based study on 500 deceased persons with SMI subjected to 
forensic autopsies under the Danish Act on Forensic Inquests and Autopsy. The autopsies followed an extended, standardised autopsy 
protocol comprised of whole-body computed tomography scanning, magnetic resonance imaging of the heart and brain and an 
extended forensic autopsy, including a wide panel of analyses (toxicology, microbiology, genetics, histology and biochemical analysis). 
Additionally, post-mortem data were linked to ante-mortem health data extracted from Danish national health registers. 
Discussion: The SURVIVE autopsy procedure, including tissue sampling and bio banking, has been shown to be effective. We expect 
that the SURVIVE study will provide unique opportunities to unravel the mechanisms and causes of premature death in persons with 
SMI. We also expect that identifying prognostic biomarkers for comorbidities will contribute to prevention of premature deaths and 
comorbidities in persons with SMI.
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Based on this, the project SURVIVE: let the dead help the living—an 
autopsy-based strategy for mapping risk markers of death among those with 
severe mental illnesses was launched in May 2013. One aim was to introduce 
a national, standardised, extended forensic autopsy procedure. The 
SURVIVE algorithm comprises known risk factors for premature death and 
comorbidities in persons with SMI, along with anthropometric measures, 
radiological imaging techniques, biomedical status measures and molecular 
analysis methods. 
The population of people suffering from SMI has higher mortality 
than the general population [3-6]. Among people suffering from, for 
example, schizophrenia, mortality is more than double [7], and life 
expectancy is 25 years lower than in an equivalent group of the general 
population (standardised mortality rate) [8, 9]. Approximately one-
thirds of deaths among persons with SMI are caused by suicides and 
accidents, while the remaining two-thirds result from natural causes, 
with cardiovascular causes accounting for nearly half of these cases [10, 
11]. 
BACKGROUND
Forensic medical research may play a key note in developing strategies to 
improve differential diagnostics within the field. These strategies can lead 
to improved clinical diagnostics and preventive strategies for comorbidities 
and premature mortality in living patients.
In 2010, the Danish Society of Forensic Medicine and the three Danish 
sections of forensic pathology, based at the universities of Aarhus, Southern 
Denmark and Copenhagen reported patterns in the causes of death among 
deceased individuals with severe mental illnesses (SMI) subjected to 
forensic autopsies [1]. The report was based on a retrospective study on 516 
cases with death certificates indicating diagnoses within sections F20-F29 
and F30-39 [2] in the 10th edition of the World Health Organization’s 
International Classification of Diseases (ICD-10). The cause of death in many 
cases was intoxication, while 10% died from cardiovascular causes. In 15% of 
cases, the cause of death could not be determined after autopsies, a higher 
rate than in other cases undergoing forensic autopsies in Denmark [1]. 
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However, the underlying reasons for the reduced life expectancy among 
people with SMI are not sufficiently established. The known risk factors are 
varied and include cardiovascular diseases (CVD) and lifestyle-related factors, 
such as diabetes, metabolic syndrome (MetS), obesity, smoking and alcohol 
and substance use [12-14]. Persons with MetS have increased all-cause 
mortality and CVD mortality risk [15]. In addition to the risk of intoxication 
and the detrimental effects of polypharmacy, several antipsychotic and 
antidepressant pharmaceuticals have been associated with increased risk of 
sudden cardiac death (SCD) [16-18].
The overall purpose of SURVIVE is to implement an autopsy strategy that 
can be used to investigate the known risk factors for premature death in a 
cohort of deceased persons suffering from SMI. These risk factors are lifestyle-
associated factors[12], MetS [19], genetic disposition [20], pharmaceuticals 
[21] and the (ab)use of alcohol and psychoactive substances [22-24]. The aim 
is to improve differential diagnostics in forensic medicine, clinical diagnostic 
tools, disease management and treatment in people with SMI within the 
healthcare sector. No major prospective or systematic autopsy studies have 
mapped the comorbidities, importance of known risk factors or causes of 
death in deceased persons with SMI.
RESEARCH QUESTIONS 
The objective of SURVIVE is to develop and employ an optimised, molecular–
biological autopsy model for deceased persons with SMI to identify the risk 
factors and causal pathways for sudden and unexpected death. Four main 
research questions are proposed:
1) What impacts does CVD have on premature death in the study population?
2) What impacts do adipose tissue changes have on the prevalence and 
severity of CVD?
3) What impacts do medication and substance use have on premature death?
4) Do genetic and epigenetic mechanisms influence medication- and 
substance-induced cardiac arrhythmia in the study population? 
Areas of interest in SURVIVE include but are not limited to: 
• patho-anatomical organ changes
• measurable indicators of MetS
• toxicological analyses
• genetic and epigenetic tests for CVD, mental illnesses and drug 
metabolism
• development of post-mortem radiological methods with post-mortem 
computer tomography (PMCT), CT angiography and post-mortem 
magnetic resonance imaging (PMMRI)
• estimation of the representativeness of the SURVIVE populations for 
Danish patients with mental illness
METHODS AND DESIGN 
Design
The SURVIVE study is a national Danish multicentre, prospective, autopsy-
based cohort study based at the Department of Forensic Medicine, 
Copenhagen University, conducted in collaboration with the Department 
of Forensic Medicine, Aarhus University, and the Department of Forensic 
Medicine, University of Southern Denmark. 
Study period
The study period was 1 May 2013–31 April 2015, and the study sample 
included 500 deceased individuals (Copenhagen=313, Aarhus=112, 
Odense=75). 
Study population
Inclusion criteria
The project prospectively included all deceased who had known or 
suspected SMI undergoing forensic autopsy at one of Denmark’s three 
departments of forensic medicine from the 1st of May 2013 and until 500 
decedents were included. Upon inclusion of each individual person in 
the SURVIVE study, the SURVIVE algorithm and workflow were activated. 
Generally, during the medico-legal inquest, the police decided whether a 
forensic autopsy should be performed based on the Danish Health Act and 
the advice of a participating medical health officer or forensic pathologist. 
The attending physician determined the presence of SMI or the 
suspicion of SMI at the time of the medico-legal examination based on 
information gathered from police reports, next of kin and statements 
from general practitioners. In some cases, the information was certain and 
supported a defined diagnosis; in others, it was vague and only indicated 
suspicion of mental illness. Suspicion included information on treatment 
with psychotropic pharmaceuticals, defined as prescribed pharmaceuticals 
with the following codes from The Anatomical Therapeutic Chemical 
classification system (ATC): N05A, N05B, N06A, N06B and N06C. Decedents 
receiving N03A pharmaceuticals were included if the indication was due 
to bipolar or other affective disorders, or the pharmaceutical was N03AE01 
(clonazepam). All cases treated with other types of benzodiazepines were 
included irrespective of the indication. Uncertain information about generic 
names, tradenames and compounds did not prevent inclusion based on the 
decision of the attending physician at the department of forensic medicine. 
The attending physician could at all times confer with a senior physician 
prior to inclusion or exclusion. Physicians employed by the forensic medical 
institutes do not have access to the electronic health care files of the health 
care system and as such, confirmation of a suspicion of SMI was not possible 
prior to inclusion.
These broad criteria were chosen to avoid missing decedents suffering 
from an SMI and to include an internal control group of the false positives - 
decedents without SMI that underwent the same specialised autopsy. 
Exclusion criteria
Exclusion criteria were extensive decomposition of the body and if a PMCT 
scan could not be performed prior to autopsy.  Exclusion also happened were 
the autopsy algorithm would prevent specialised examination required for 
police investigation (e.g. homicide).Cases in which consent for the SURVIVE 
project was not given after the autopsy were excluded from further analysis. 
Consent
Under Danish legislation, all research protocols involving biological samples 
from forensic autopsies require informed consent from the next of kin. A 
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detailed plan to contact the next of in was accordingly developed. Written 
information about the SURVIVE study, including the need for consent and 
instructions how to contact the research team by email or phone, was 
mailed by post to the next of kin no less than three months after an autopsy 
was performed. In the case of no reply, a follow-up phone call was made. 
All information regarding consent, contact information of next of kin and 
other comments about the information process was recorded in a separate 
Microsoft Access 2010™ (Microsoft®, Redmond, Washington, USA) database 
separate from the data registered for the research purposes on each 
individual case. Cases in which relatives did not give consent were excluded 
from SURVIVE. Obtaining consent was completed in May 2017, and the 
consent rate from next of kin was higher than 90%.
Blinding
All cases were assigned a unique project identification (ID) number (SURVIVE-
ID) upon inclusion in the study. The case ID numbers and the corresponding 
data were recorded in an Access database. De-anonymisation was done 
using a separate table linking the project IDs to the social security numbers 
of the deceased. Police reports, autopsy reports and correspondence 
concerning individual cases were not recorded in the database. Case-specific 
results obtained in the SURVIVE project were not available to investigation 
of individual cases.
SURVIVE protocol
Post-mortem radiology 
All cases were subjected to whole-body PMCT scanning before autopsy at 
a department of forensic medicine. Either a Siemens CT scanner Somatom 
Definition, 64 slice or a Somatom Spirit dual slice was used. Scan protocols 
adhered to the more recent standards from the Danish Accreditation 
and Metrology Fund (DANAK) following international standard ISO/IEC 
17020:2012. The protocols included both routine scans and scans specifically 
for individual SURVIVE projects (e.g. cardiac CT, lumbar spine and hips for 
bone mass density (tables 1–4).
SURVIVE scan protocols for PMCT at the three departments of forensic 
medicine in Denmark (tables 1–4)
Table 1. CT scan protocol, Department of Forensic Medicine, University of Copenhagen 
  Head and neck Thorax and abdomen Lower extremities Cardiac  calcium score Lumbar spine and hips
mAs 260 90 90 157 200 
kV 120 120 120 120 120
Slice (mm) 1.0 3.0 3.0 3.0 3.0 
Pitch 0.4 0.24 0.6 0.75 0.95
Kernel H20s
H60s
B31f B31f B30f B50f
Scanner Siemens Somatom Sensation 4, May–October 2013
Table 2. CT scan protocol, Department of Forensic Medicine, University of Copenhagen
  Head and neck Thorax and abdomen Lower extremities Cardiac  calcium score Lumbar spine and hips Whole body
mAs 375 47/40 114 147 275 570
kV 140 120 120 120 120 120
Slice (mm) 1.0 3.0/1.0 1.0 3 3.0/1.0 3.0
Pitch 0.75 0.5/0.45 0.85 0.35 0.35 1.5
Kernel H20s B30f/B20f B20s/B40s B35f B20f B30f
Scanner Siemens Somatom Definition, 64 slice, October 2013–May 2015
Table 3. CT scan protocol, Department of Forensic Medicine, University of Aarhus 
  Head and neck Thorax and abdomen Lower extremities Cardiac  calcium score Lumbar spine and hips
mAs 500 300 200 210 200 
kV 140 120 120 120 120
Slice (mm) 1.0 1.5 1.0 3.0 3.0 
Pitch 0.75 0.5 0.85 0.5 0.95
Kernel H20s
H60
B20f
B70f 
B20s 
B40s 
B35f B20f
Scanner Siemens Somatom Definition, 64 slice, May 2013-May 2015
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In selected cases, PMCT angiography and PMMRI of the heart and brain 
were performed.
Extended autopsy algorithm
The standardised autopsy algorithm followed the most recent accredited 
standards from DANAK. The SURVIVE algorithm built on it by thoroughly 
describing the registration of physical parameters and anthropometric 
measurements and the dissection and sampling of each relevant organ 
(Table 5), focusing on the dissection and registration of heart parameters 
(Table 6). Dissection of the heart was performed according to international 
standards [25].
The material needed for registration, sampling and data collection was 
supplied in an individually assigned cardboard box with a unique SURVIVE-
ID. The cardboard box was suitable for the autopsy room and provided 
before the autopsy. Specifically assigned medical personnel performed all 
registrations before and during each autopsy (see tables 7–8).
Sampling
The location and sidedness (left or right) of the sample from each organ and 
tissue were standardised. In addition to the standard autopsy protocol, the 
samples included peripheral blood and tissue from skeletal muscles, liver, 
spleen, heart and brain; bone samples from the second lumbar vertebrae 
and the iliac crest; and hair samples. All tissue and fluid samples were 
collected in tubes without any additives (15 mL and 5mL, respectively). 
The relevant samples were stored at -20°C or -80°C until analysis. Tissue for 
histopathological analyses was fixed in 4% formalin and then embedded 
in paraffin. Finally, blood was added to DNA filter paper (FTA™ Classic Card, 
Fitzco, Minneapolis, USA) and stored at room temperature for later analyses. 
Sample analysis
Members of the steering group of the SURVIVE-study, who were all certified 
clinical and forensic pathologists, based histopathological description on a 
consensus decision. The forensic toxicological analysis after the autopsy was 
performed at all three forensic chemistry departments following the current 
DANAK standards under the international standard ISO/IEC 17025:2005. 
All the toxicological analyses also adhered to an intersectional, approved 
standard for medication and drug types, analyses matrices and intoxication 
levels. The analyses comprised screening and quantification of prescribed 
pharmaceuticals and illicit psychoactive substances, including active 
metabolites from several samples (Table 9).
Additional forensic biochemical, microbiological and molecular biology 
analyses (tables 9 and 10) were performed, including but not limited to 
post-mortem measurements of blood total cholesterol levels, triglycerides, 
glycated haemoglobin (HbA1c) and urine-albumin/creatinine ratio. 
Other data sources
The 500 cases were supplemented with register-based data from the 
Danish national health registers (see Table 11) including, but not limited 
to: information on dispensed prescription medication, contacts with 
primary health care providers, admissions to hospitals including emergency 
wards, ambulatory functions and long term admission, use of involuntary 
commitment in the psychiatric health care system and registration in 
substance use treatment facilities, 
Study outcomes/SURVIVE—an umbrella for several studies 
SURVIVE has yielded extensive data and bio sampling serving as entry 
points for sub-projects relevant to premature death and comorbidities in the 
population with SMI. Furthermore, the SURVIVE study provides opportunities 
for the development and improvement of autopsy techniques. To answer 
the central research questions of the SURVIVE study, several PhD students 
Table 4. CT scan protocol, Department of Forensic Medicine, University of Southern Denmark 
  Head  Neck Thorax Abdomen Lower extremities Cardiac  calcium  score Lumbar spine and hips
mAs 110 110 60 80 30 60 30
kV 130 130 130 130 130 130 130
Slice (mm) 3.0 3.0 5.0 5.0 5.0 3.0 3.0
Pitch 0.95 0.95 1.8 1.8  1.0 1.0 1.0
Kernel H31
H60
B50 B31
B70
B41 U90 B31 U90
Scanner Siemens Somatom Spirit Dual Slice, May 2013-May 2015. Each CT scanner was equipped with a calibration phantom containing different concentrations 
of hydroxyapatite. The phantoms were supplied by the firm Image Analysis, Inc. Additionally, the CT scanner in Aarhus was equipped with a calibration phantom 
specifically designed for the measurement of bone mass density by the firm QCT Pro, Mindways Software.
Table 5. Registration of physical and organ-specific parameters
Registrations of physical para-
meters
Organ-specific registrations
Height Brain weight
Weight Thyroid weight
Abdominal circumference Lung weight (left and right)
Hip circumference Omentum weight
CRP measurement Kidney capsule weight
Hair length Spleen weight
Hair treatment Liver weight
Hair colour Liver measurements (h x l x d)a
Kidney weight
Kidney measurements (h x l x d)a
Heart (see Table 6)
ah x l x d: height x length x depth
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Table 6. Registration of cardiac parameters
Heart Ventricle measure-
ments (cm) 
Ostia
circumference 
(cm)
Coronary artery ostia Grade of 
coronary artery 
disease
Morphological change 
Weight (gram) Left ventricle (anterior, 
lateral, posterior)
Aorta Appearance (round, oval 
or other)
0 None
Measurements 
A (along the sulcus corona-
rius) x B (perpendicular to A, 
from the sulcus coronarius 
to the apex) x C (height of 
heart lying on the posterior 
side, anterior side facing 
upwards) 
Right ventricle (anterior, 
lateral and posterior)
Mitral Localisation related to the 
commissure (above the 
commissure line, in the 
commissure line or bene-
ath the commissure line)
1 Fatty streaks
Septum (from left to 
right ventricle)
Tricuspid Localisation related to va-
lve insertion (in insertion, 
not in insertion)
2 Plaque
Pulmonary Patency (dia> 2 mm) 3 Plaque with bleeding
4 Arteriosclerosis
5A Stenosis
none
5B Stenosis 
1%–25%
5C Stenosis 
26%–50%
5D Stenosis
51%–75%
5E Stenosis
76%–99%
5F Occlusion
100%
Table 7. Collection of existing demographic, epidemiological and disease-related data connected to project inclusion
General characteri-
stics
Psychiatric
disease
Medication Related paraclinical 
values (e.g. biochemi-
stry or ECG)
Lifestyle
Date of birth Schizophrenia Antipsychotics Kidneys Smoking habits
Date of death Depression Antidepressants Liver Alcohol abuse
Gender Bipolar Other Thyroid Drug abuse
Municipality of residence Other Heart
Next of kin Cholesterol
Citizenship CRP
Ethnicity None
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and postdocs have been enrolled and started 17 subprojects by December 
2017 (Table 12). 
Statistical considerations
For each individual subproject, the project team handles the data, supervised 
by the project manager. Statens Serum Institut, under the Danish Ministry 
of Health, supports data retrieval and analyses of the national registries. 
The methods, statistical analysis, programmes and sample size vary among 
the subprojects. Those involving tissue and fluid analyses use only relevant 
samples from cases with consent from next of kin, while other subprojects 
involving only registry- and PMCT/PMMR-scan data have samples from all 
500 cases. 
Organisation
The SURVIVE study covers all of Denmark and is embedded in a partnership 
among the three Danish departments of forensic medicine. Project 
management is handled by the Department of Forensic Medicine, University 
of Copenhagen. Several specialised teams have been formed, including 
data management, pathology, psychiatry, toxicology, genetic, post-mortem 
radiology, cardiology and registry research groups. See the appendix for the 
participants and collaborators.
DISCUSSION
Extended autopsies of persons with SMI may help uncover a range of 
conditions highly important for the survival of these persons. The project 
autopsy algorithm enables investigations, sampling and analyses impossible 
to perform in the living. Not all organ changes can be detected with 
radiological imaging, biopsies or surgical interventions. Direct observation 
of organs and subsequent tissue microscopy, forensic toxicological analysis 
and molecular biological testing may contribute detailed information that 
substantially supplements the methods applied to examination of the living. 
We expect that by optimising the forensic autopsy of deceased persons 
with SMI, SURVIVE will increase knowledge of somatic disease, organ 
change, substance abuse, metabolism of pharmaceuticals and acquired and 
congenital genetic variations. This knowledge may facilitate the prevention 
of lower life expectancy and higher mortality among persons with SMI. The 
symptom complex of lifestyle-related disorders in those with mental illness 
appears to be an exacerbated version of the general population; therefore, 
we expect general benefits from the SURVIVE results. 
LIMITATIONS AND CONCERNS
The medicolegal system setting and the Danish Act on Forensic Inquests limit 
the number of included cases with SMI. The police decide whether further 
investigations warrant forensic autopsy. Consequently, the SURVIVE study does 
not include the deaths of persons with SMI the police decide not to refer for 
forensic autopsies. Deaths not subjected to legal inquest, such as hospital deaths 
and clinical autopsies performed in hospital settings, are not included. The 
included cases thus are subject to selection bias. The SURVIVE inclusion criteria are 
very broad to ensure forming a sufficiently large group of controls that do not fulfil 
the criteria for a verified diagnosis within the ICD-10 F2 or F3 sections. 
SURVIVE is the first Danish forensic research project requiring consent. 
The setup of the medico-legal system and autopsies required immediate 
sampling for the study, and it was not possible to ask relatives for informed 
consent before the autopsies. When contacted several months after the 
autopsies, many relatives gave consent but also expressed a degree of 
re-traumatisation by the contact in a situation of grief. Although the final 
study group of 500 is high by forensic pathology standards, the study group 
Table 8. Tissue samples for histopathology
Organ Specific location
Omentum None
Brain Frontal cortex
Hippocampus
Internal capsule
Pons
Medulla oblongata
Cerebellum
Hypophysis
Thyroid gland Lobe
Lung Superior lobe
Inferior lobe
Lymph node Bifurcation
Aorta Sinus part
Abdominal part
Spleen Including capsule
Pancreas Caput
Liver Anterior
Posterior
Central
Kidney Parenchymatous width
Suprarenal gland
Subcutaneous fat Abdomen
Buttock
Muscle M. vastus lateralis
Bone marrow Second lumbar corpora
Uterus/prostate -
Ovary/testes -
Heart Atrium
Ventricular ejection area
Papillary muscle
Epicardial fat, three areas
Ventricle anterior
Ventricle lateral
Ventricle posterior
Septum anterior
Septum posterior
Coronary arteries Left coronary artery
Descending branch
Circumflex branch
Right coronary artery
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Table 9. Aliquot biobank samples and subsequent supplementary analyses
Aliquot biobank samples Toxicology Microbiology Clinical biochemistry
Blood (peripheral and heart blood) X X (heart blood) X
Spinal fluid X X X
Urine X - X
Vitreous humour X - X
Tonsil tissue X X -
Brain tissue X X -
Heart tissue X X -
Liver tissue X X -
Muscular tissue X - -
Lung tissue - X -
Epicardial fat - - -
Omentum - - -
Abdominal fat - - -
Buttocks fat - - -
Blood spot/filter paper - X -
Hair X - -
Tissue for microscopy (see Table 8) - - -
Bone from crista iliaca - - -
Lumbar vertebrae corpus - - -
is small compared to studies among the living [6, 26, 27]. This poses some 
constraints for the selection of individual research questions. 
ABBREVIATIONS
AAU—University of Aalborg
AU—University of Aarhus
CT—computed tomography
CVD —cardiovascular disease
DANAK—Danish Accreditation and Metrology Fund
KU—University of Copenhagen
MetS—metabolic syndrome
MRI—magnetic resonance imaging
PMMRI—post-mortem magnetic resonance imaging
PMCT—post-mortem computed tomography
RH—Rigshospitalet, hospital in Copenhagen
SCD—sudden cardiac death
SDU—University of Southern Denmark
SMI—severe mental illness
SUD—substance use disorder
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Table 10. Biochemical analyses
Aliquot biobank sample Analyses
Blood Triglyceride
Total cholesterol
CRP
HbA1c
Glucose
Urine Creatinine
Albumin
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Table 11. Danish national health register data on psychiatric, physical state and health issues
Name of national health register Types of data retrieved for each individual person
National Patient Register Somatic care:
- Admission and discharge dates
- Reason for admittance
- Diagnoses
- Treatment provided
Psychiatric care:
- Admission and discharge dates
- Reason for admittance
- Self-harm
- Diagnosis
- Treatment provided
Register of Medicinal Product Statistics Medication:
- Prescription
- Dosage
- Date of retrieval of dispensed medication
- Indications for prescription
National Alcohol Treatment Register Alcohol abuse:
- Types of abuse
- Severity
- Substitution medications
- Other types of medication
Register of Drug Abusers Undergoing Treatment Drug abuse:
- Types of abuse
- Drugs in use
- Substitution medications
Involuntary Commitment Register Psychiatric care:
- Start and end date of involuntary commitment
- Type of involuntary commitment used (isolation, electro-shock-therapy, medication, etc)
- Reasons for involuntary commitment
Danish Psychiatric Central Register Psychiatric care:
- Admission and discharge dates
- Reason for admittance
- Self-harm
- Diagnoses
- Treatment provided
Health Security System Primary health care system:
- Contacts
- Type of primary health care practitioner
Table 13. Subprojects under SURVIVE as of December 2017
PhD projects
1 Pato-anatomic organ changes: lifestyle or medication 
2 Metabolism and inflammation in fatty tissue
3 Prognostic markers for cardiovascular disease by calcium score and imaging
4 Polypharmacy and arrhythmogenic death
5 Correlation between osteoporosis and treatment with antipsychotic medications
6 Identifying the mechanisms underlying premature death in persons suffering from 
schizophrenia or severe depression, a registry-based study
7 Hair analysis for medications, illicit substances and the stress cursor cortisol
8 Analysis of medication and illicit substances in tissues and biological fluids to understand the unexpected deaths of mentally ill individuals
9 Stress-related morphological changes 
Postdoc projects
10 Genetic-associated arrhythmias vs sudden cardiac death 
11 Heart morphology and MRI, T2 quantification
12 Epigenetics: drug-induced sudden cardiac death among individuals with schizophrenia
Scholarships
13 Kidney damage: pharmacologically induced kidney injury in individuals with schizophrenia 
14 Virtual organ measurement (CT & MRI): method development
15 Obesity and fatty hearts
16 CT-based volumetric study of hippocampus
17 Steatosis myocardii, fatty infiltration in the myocytes
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However, data can be made available from the authors upon reasonable 
requests and with permission from the Danish Data Protection Agency.
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APPENDIX
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Emeritus Jørgen Lange Thomsen, SDU; Deputy Chief Forensic Pathologist 
Peter Thiis Knudsen, SDU;
Clinical pathology: Professor Ulrik Baandrup, AAU; Professor Niels Marcussen, 
SDU;
Clinical associate professor Sönke Detlefsen, SDU;
Psychiatry: Professor Merete Nordentoft, KU; Professor Martin Balslev, KU; 
Clinical associate professor John Teilmann Larsen, SDU;
Cardiology: Clinical associate professor Klaus Fuglsang Kofoed, RH; Dr. Niels 
Vejlstrup, RH;
Toxicology: Professor Kristian Linnet, KU; Associate professor Sys Stybe 
Johansen, KU; Senior researcher Jørgen Hasselstrøm, AU; forensic chemist 
Jakob Jornil, AU;
Radiology: Professor Carsten Thomsen, RH; Dr. Karl Erik Jensen, RH;
Osteology: Professor Ellen Magrethe Hauge, AU; Associate Professor Michel 
Dalstra, AU;
Genetics: Professor Niels Morling, KU; Senior consultant Claus Børsting, KU;
Statistics: Professor Claus Ekstrøm, KU; Senior researcher Heather Boyd, SSI, 
KU; Professor Niels Lynnerup, KU;
Pharmacology: Professor Jørgen Rungby, AU, KU;
Anthropology: Professor Niels Lynnerup, KU;
Neuroanatomy: Professor Emeritus Morten Møller, KU;
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